1. Home
  2. TNET vs ZLAB Comparison

TNET vs ZLAB Comparison

Compare TNET & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriNet Group Inc.

TNET

TriNet Group Inc.

SELL

Current Price

$70.34

Market Cap

3.0B

ML Signal

SELL

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$23.51

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNET
ZLAB
Founded
1988
2013
Country
United States
China
Employees
2700
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
2000
2017

Fundamental Metrics

Financial Performance
Metric
TNET
ZLAB
Price
$70.34
$23.51
Analyst Decision
Hold
Strong Buy
Analyst Count
7
12
Target Price
★ $66.20
$33.14
AVG Volume (30 Days)
271.2K
★ 706.0K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 1.73%
N/A
EPS Growth
N/A
★ 38.46
EPS
★ 3.05
N/A
Revenue
★ $5,010,000,000.00
$460,156,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.89
$26.50
P/E Ratio
$21.95
★ N/A
Revenue Growth
N/A
★ 15.33
52 Week Low
$33.67
$15.96
52 Week High
$73.08
$29.77

Technical Indicators

Market Signals
Indicator
TNET
ZLAB
Relative Strength Index (RSI) 62.98 42.24
Support Level $64.84 $16.97
Resistance Level $71.56 $27.14
Average True Range (ATR) 2.23 1.06
MACD 0.60 -0.33
Stochastic Oscillator 97.88 29.58

Price Performance

Historical Comparison
TNET
ZLAB

About TNET TriNet Group Inc.

Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: